Showing 741-750 of 1367 results for "".
- Green Living Environments Don't Protect Kids from Eczemahttps://practicaldermatology.com/news/green-living-environments-dont-protect-kids-from-eczema/2461675/Greenness or the significant presence of living vegetation around the home in early childhood does not seem to protect children from atopic eczema, a new Finnish study shows. Instead, the proximity of coniferous, mixed forests and agricultural areas was associated with elevated risk of
- Skin Cancer Foundation Hits the Road: Destination Healthy Skin Program Kicks Off on May 6, 2023https://practicaldermatology.com/news/skin-cancer-foundation-hits-the-road-destination-healthy-skin-program-kicks-off-on-may-6-2023/2461669/The Skin Cancer Foundation will launch its annual mobile education and screening program, Destination Healthy Skin, on Saturday, May 6, in Greenwich, Connecticut. The program educates the public about the importance of skin cancer early detection and effective sun p
- Building a Better Sunscreen: Is Rosmarinic Acid the Key?https://practicaldermatology.com/news/building-a-better-sunscreen-is-rosmarinic-acid-the-key/2461646/Rosmarinic acid may enhance sunscreen efficacy without increasing concentration of conventional UV filters, a new study in Cosmetics suggests. When 0.1% Rosmarinic acid an active antioxidant was added
- Leo Pharma's Adbry Reduces S. aureus Skin Colonization in Kids With ADhttps://practicaldermatology.com/news/leo-pharmas-adbry-reduces-s-aureus-skin-colonization-in-kids-with-ad/2461616/Leo Pharma’s Adbry (tralokinumab-ldrm) significantly reduced the abundance of Staphylococcus aureus in the lesional and non-lesional skin of adolescents with atopic dermatitis (AD) after 16 weeks, according to new data presented at the American Academy of Dermatology
- Aditxt Forms Adimune, Inc.; Appoints Dr. Friedrich Kapp as Chairman and CEOhttps://practicaldermatology.com/news/aditxt-forms-adimune-inc-appoints-dr-friedrich-kapp-as-chairman-and-ceo/2461479/Aditxt, Inc. has formed Adimune
- Cosmetic Surgery Forum 2022 Kicks Off in Nashvillehttps://practicaldermatology.com/news/cosmetic-surgery-forum-2022-kicks-off-in-nashville/2461451/Now in its 14th year, the 2022 Cosmetic Surgery Forum is once again taking Nashville by storm with new faculty members, a new roundtable, and exciting new topics along with the frank discussions, candor, and live demos that attendees have come to expect. “CSF 2022 is our be
- High Rates of Skin Conditions Seen Among Urban-living Indigenous Kids in High-Income Countrieshttps://practicaldermatology.com/news/high-rates-of-skin-conditions-seen-among-urban-living-indigenous-kids-in-high-income-countries/2461421/Many urban-living Indigenous children and young people in high-income countries are burdened with atopic dermatitis and bacterial skin infections, according to Aasystematic analysis in Pediatric Dermatology. Invest
- Study: Psoriasis Does Not Appear to Increase Heart Attack Risk in People with Significant Kidney Diseasehttps://practicaldermatology.com/news/study-psoriasis-does-not-appear-to-increase-heart-attack-risk-in-people-with-significant-kidney-disease/2461387/Studies have suggested that psoriasis is an independent risk factor for heart attack in the general population, but investigators recently found that in people who also have end-stage renal disease, which shares many risk factors with heart disease, it is not. “There are a lot of
- EADV 2022 News: Otezla Works Well in Kids with PsO, Adults with Genital PsOhttps://practicaldermatology.com/news/eadv-2022-news-otezla-works-well-in-kids-with-pso-adults-with-genital-pso/2461332/Otezla (apremilast) performs well in pediatric patients with moderate to severe plaque psoriasis and in adults with moderate to severe genital psoriasis, according to new research presented at the 31st European Academy of Dermatology and Venereology (EADV) Congress in Milan, Italy. 
- Expert FDA Panel Recommends Skin Lesion Analyzers and Apps for Skin Cancer Detection Keep Class III Statushttps://practicaldermatology.com/news/expert-fda-panel-recommends-skin-lesion-analyzers-and-apps-for-skin-cancer-detection-keep-class-iii-status/2461293/The FDA held a meeting with the Medical Devices Advisory Committee in late July to gather expert advice on the regulation of AI driven, skin lesion analyzers (SLAs) and Apps for skin cancer detection. Panel members urged caution for skin cancer detection SLAs and Apps and stressed the need for mo